aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
aTYR PHARMA reports 2019 executive compensation
By ExecPay News
Published: April 2, 2020
aTYR PHARMA reported fiscal year 2019 executive compensation information on April 2, 2020.
In 2019, three executives at aTYR PHARMA received on average a compensation package of $523K, a 35% decrease compared to previous year.
Average pay of disclosed executives at aTYR PHARMA
Sanjay S. Shukla, Chief Executive Officer, received $664K in total, which decreased by 52% compared to 2018. 68% of Shukla's compensation, or $450K, was in salary. Shukla also received $96K in non-equity incentive plan, $82K in option awards, $26K in stock awards, as well as $10K in other compensation.
Jill M. Broadfoot, Chief Financial Officer, received a compensation package of $455K, which increased by 36% compared to previous year. 77% of the compensation package, or $350K, was in salary.
Nancy E. Denyes, General Counsel, earned $449K in 2019.
Related executives
You may also like
Source: SEC filing on April 2, 2020.